{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:05:22Z","timestamp":1789517122549,"version":"build-2803163510"},"reference-count":50,"publisher":"The Endocrine Society","issue":"10","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100003287","name":"Rally Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003287","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006458","name":"The Children\u2019s Hospital of Philadelphia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006458","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Differentiated thyroid carcinoma (DTC) is rare in children, comprising 2% to 4% of pediatric cancers. Because of low case volumes at individual institutions, comprehensive data on patient and tumor characteristics and treatment outcomes are limited. The Child and Adolescent Thyroid Consortium was established in 2019 to address this gap and to assess impact of changes in practice on outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This inaugural Child and Adolescent Thyroid Consortium study analyzes the landscape of pediatric DTC and predictors of invasive disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>International, multicenter retrospective analysis of children (&amp;lt;age 19 years) with DTC diagnosed from 2010 to 2019.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Five high-volume pediatric centers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cohort included 715 children (78.3% female) diagnosed with DTC at median age 15.2 years (range: 3.2-18.9). There were 673 (94%) patients with papillary thyroid carcinoma (PTC) and 42 (6%) had follicular thyroid carcinoma. Among patients with PTC, stage 1(M0) disease was present in 562 individuals (83.5%; 222 N0, 161 N1a, and 179 N1b). Stage 2 (M1) disease was present in 111 (16.5%) children with PTC and 1\/42 (2.4%) with follicular thyroid carcinoma. Males and children aged &amp;lt;10 years exhibited more advanced T, N, and M stages. Any extrathyroidal extension correlated with increased nodal and pulmonary metastases. Oncogenic fusions, compared with BRAFV600E, were associated with more advanced N and M stages. Deintensification of therapy since 2015 was not associated with changes in disease outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Invasive DTC is associated with age &amp;lt;10 years, male sex, tumors driven by oncogenic fusions, and extrathyroidal extension. Despite less aggressive therapies in recent years, disease outcomes have not worsened. Recognition of these associations may guide care and prognostication.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgag172","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:26:58Z","timestamp":1776770818000},"page":"2837-2849","source":"Crossref","is-referenced-by-count":0,"title":["The landscape of pediatric differentiated thyroid carcinoma and predictors of invasive disease: a CATC study"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7088-8146","authenticated-orcid":false,"given":"Jonathan D","family":"Wasserman","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, The Hospital for Sick Children , Toronto, ON M5G 1X8 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0863-7500","authenticated-orcid":false,"given":"Amber R","family":"Isaza","sequence":"additional","affiliation":[{"name":"Division of Endocrinology & Diabetes, Children's Hospital of Philadelphia , Philadelphia, PA 19104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0280-0100","authenticated-orcid":false,"given":"Steven G","family":"Waguespack","sequence":"additional","affiliation":[{"name":"Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center , Houston, TX 77030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0894-9301","authenticated-orcid":false,"given":"Ari J","family":"Wassner","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Boston Children's Hospital , Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1677-5228","authenticated-orcid":false,"given":"Aime T","family":"Franco","sequence":"additional","affiliation":[{"name":"Division of Endocrinology & Diabetes, Children's Hospital of Philadelphia , Philadelphia, PA 19104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6277-0906","authenticated-orcid":false,"given":"Emily","family":"Christison-Lagay","sequence":"additional","affiliation":[{"name":"Division of Pediatric Surgery-Department of Surgery, Yale School of Medicine , New Haven, CT 06520 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2336-2245","authenticated-orcid":false,"given":"Catherine A","family":"Dinauer","sequence":"additional","affiliation":[{"name":"Section of Endocrinology & Diabetes, Department of Pediatrics, Yale School of Medicine , New Haven, CT 06520 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Baran","sequence":"additional","affiliation":[{"name":"Division of Endocrinology & Diabetes, Children's Hospital of Philadelphia , Philadelphia, PA 19104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0629-0160","authenticated-orcid":false,"given":"Mya","family":"Bojarsky","sequence":"additional","affiliation":[{"name":"Division of Endocrinology & Diabetes, Children's Hospital of Philadelphia , Philadelphia, PA 19104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3952-881X","authenticated-orcid":false,"given":"Andrew J","family":"Bauer","sequence":"additional","affiliation":[{"name":"Division of Endocrinology & Diabetes, Children's Hospital of Philadelphia , Philadelphia, PA 19104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"2026091519582315500_dgag172-B1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijporl.2016.08.005","article-title":"Pediatric thyroid cancer: an update from the SEER database 2007-2012","volume":"89","author":"Dermody","year":"2016","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"1","key":"2026091519582315500_dgag172-B2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1634\/theoncologist.12-1-20","article-title":"Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program","volume":"12","author":"Hayat","year":"2007","journal-title":"Oncologist"},{"key":"2026091519582315500_dgag172-B3"},{"key":"2026091519582315500_dgag172-B4","author":"Statistics Canada"},{"key":"2026091519582315500_dgag172-B5","author":"Surveillance Epidemiology and End Results (SEER) Program-National Cancer Institute"},{"issue":"6","key":"2026091519582315500_dgag172-B6","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-22-0180","article-title":"Pediatric thyroid cancer guidelines: challenges in stratifying care based on limited data","volume":"11","author":"Bauer","year":"2022","journal-title":"Eur Thyroid J"},{"issue":"1","key":"2026091519582315500_dgag172-B7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000484170","article-title":"Survey on paediatric differentiated thyroid cancer care in Europe","volume":"89","author":"Dekker","year":"2018","journal-title":"Horm Res Paediatr"},{"key":"2026091519582315500_dgag172-B8","volume-title":"Cancer Facts & Figures 2024","author":"American Cancer Society","year":"2024"},{"issue":"1","key":"2026091519582315500_dgag172-B9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jss.2009.03.098","article-title":"Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients","volume":"156","author":"Hogan","year":"2009","journal-title":"J Surg Res"},{"issue":"7","key":"2026091519582315500_dgag172-B10","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1089\/thy.2014.0460","article-title":"Management guidelines for children with thyroid nodules and differentiated thyroid cancer","volume":"25","author":"Francis","year":"2015","journal-title":"Thyroid"},{"issue":"6","key":"2026091519582315500_dgag172-B11","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-22-0146","article-title":"2022 European Thyroid Association guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma","volume":"11","author":"Lebbink","year":"2022","journal-title":"Eur Thyroid J"},{"issue":"11","key":"2026091519582315500_dgag172-B12","first-page":"G1","article-title":"Paediatric differentiated thyroid carcinoma: a UK National Clinical Practice Consensus Guideline","volume":"29","author":"Howard","year":"2022","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"2026091519582315500_dgag172-B13","doi-asserted-by":"crossref","first-page":"P11","DOI":"10.1530\/EJE-20-0191","article-title":"New national recommendations for the treatment of pediatric differentiated thyroid carcinoma in the Netherlands","volume":"183","author":"Lebbink","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026091519582315500_dgag172-B14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.6065\/apem.2448296.148","article-title":"Pediatric thyroid cancer: key considerations based on the 2024 Korean Thyroid Association Differentiated Thyroid Cancer Management Guidelines","volume":"30","author":"Lee","year":"2025","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"6","key":"2026091519582315500_dgag172-B15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.5603\/ep.103845","article-title":"Diagnostics and treatment of differentiated thyroid carcinoma in children - Guidelines of the Polish National Scientific Societies, 2024 Update","volume":"75","author":"Handkiewicz-Junak","year":"2024","journal-title":"Endokrynol Pol"},{"issue":"4","key":"2026091519582315500_dgag172-B16","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/hed.26586","article-title":"Consensus statement by the American Association of Clinical Endocrinology (AACE) and the American Head and Neck Society Endocrine Surgery Section (AHNS-ES) on Pediatric Benign and Malignant Thyroid Surgery","volume":"43","author":"Stack","year":"2021","journal-title":"Head Neck"},{"key":"2026091519582315500_dgag172-B17","doi-asserted-by":"publisher","DOI":"10.5683\/SP3\/GWIZPR"},{"issue":"2","key":"2026091519582315500_dgag172-B18","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"2","key":"2026091519582315500_dgag172-B19","first-page":"93","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2026091519582315500_dgag172-B20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12022-022-09712-6","article-title":"Special issue on the 2022 WHO classification of endocrine and neuroendocrine tumors: a new primer for endocrine pathology practice","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"issue":"1","key":"2026091519582315500_dgag172-B21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"issue":"2","key":"2026091519582315500_dgag172-B22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0042-1750334","article-title":"Applicability of adults 2015 American Thyroid Association differentiated thyroid cancer guidelines for postoperative risk stratification and postradioiodine treatment dynamic risk stratification in pediatric population","volume":"21","author":"Singh","year":"2022","journal-title":"World J Nucl Med"},{"issue":"2","key":"2026091519582315500_dgag172-B23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/thy.2017.0214","article-title":"Practical initial risk stratification based on lymph node metastases in pediatric and adolescent differentiated thyroid cancer","volume":"28","author":"Jeon","year":"2018","journal-title":"Thyroid"},{"issue":"6","key":"2026091519582315500_dgag172-B24","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1089\/thy.2021.0666","article-title":"Serum thyroglobulin measurement following surgery without radioactive iodine for differentiated thyroid cancer: a systematic review","volume":"32","author":"Chou","year":"2022","journal-title":"Thyroid"},{"issue":"4","key":"2026091519582315500_dgag172-B25","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4174\/astr.2018.95.4.222","article-title":"Usefulness of dynamic risk stratification in pediatric patients with differentiated thyroid carcinoma","volume":"95","author":"Kim","year":"2018","journal-title":"Ann Surg Treat Res"},{"key":"2026091519582315500_dgag172-B26","author":"IBM Corp"},{"issue":"22","key":"2026091519582315500_dgag172-B27","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1158\/0008-5472.CAN-21-0761","article-title":"Diverse oncogenic fusions and distinct gene expression patterns define the genomic landscape of pediatric papillary thyroid carcinoma","volume":"81","author":"Stosic","year":"2021","journal-title":"Cancer Res"},{"key":"2026091519582315500_dgag172-B28","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.00102","article-title":"Update on fundamental mechanisms of thyroid cancer","volume":"11","author":"Prete","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2026091519582315500_dgag172-B29","article-title":"Reevaluating the prognostic significance of male gender for papillary thyroid carcinoma and microcarcinoma: a SEER database analysis","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"issue":"10","key":"2026091519582315500_dgag172-B30","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1200\/JCO.21.01861","article-title":"Fusion oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers","volume":"40","author":"Franco","year":"2022","journal-title":"J Clin Oncol"},{"issue":"18","key":"2026091519582315500_dgag172-B31","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144847","article-title":"NTRK and RET fusion-directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptake","volume":"131","author":"Lee","year":"2021","journal-title":"J Clin Invest"},{"issue":"7","key":"2026091519582315500_dgag172-B32","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1089\/thy.2019.0229","article-title":"Extrathyroidal extension is an important predictor of regional lymph node metastasis in pediatric differentiated thyroid cancer","volume":"30","author":"Jain","year":"2020","journal-title":"Thyroid"},{"issue":"8","key":"2026091519582315500_dgag172-B33","doi-asserted-by":"crossref","first-page":"e3016","DOI":"10.1210\/clinem\/dgz121","article-title":"Does microscopic extrathyroidal extension confer a higher risk of recurrence in patients with well-differentiated thyroid cancer?","volume":"105","author":"Pacini","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026091519582315500_dgag172-B34","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1210\/clinem\/dgad322","article-title":"Outcomes of ATA low-risk pediatric thyroid cancer patients not treated with radioactive iodine therapy","volume":"108","author":"Bojarsky","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026091519582315500_dgag172-B35","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31545","article-title":"Multicenter retrospective analysis of pediatric differentiated thyroid carcinoma: treatment practices and outcomes prior to pediatric American Thyroid Association guidelines implementation","volume":"72","author":"Mahajan","year":"2025","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"2026091519582315500_dgag172-B36","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/hed.27098","article-title":"The 2015 American Thyroid Association guidelines and trends in hemithyroidectomy utilization for pediatric thyroid cancer","volume":"44","author":"Stein","year":"2022","journal-title":"Head Neck"},{"issue":"2","key":"2026091519582315500_dgag172-B37","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1210\/clinem\/dgae576","article-title":"Pediatric papillary thyroid carcinoma: outcomes after surgery without adjuvant radioactive iodine","volume":"110","author":"Castellanos","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026091519582315500_dgag172-B38","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1210\/jc.2018-01690","article-title":"Lung metastasis in pediatric thyroid cancer: radiological pattern, molecular genetics, response to therapy, and outcome","volume":"104","author":"Alzahrani","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026091519582315500_dgag172-B39","doi-asserted-by":"crossref","first-page":"e3981","DOI":"10.1210\/clinem\/dgaa545","article-title":"Distant metastasis in pediatric and adolescent differentiated thyroid cancer: clinical outcomes and risk factor analyses","volume":"105","author":"Sugino","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026091519582315500_dgag172-B40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/thy.2020.0002","article-title":"Lung metastasis in children with differentiated thyroid cancer: factors associated with diagnosis and outcomes of therapy","volume":"31","author":"Chesover","year":"2021","journal-title":"Thyroid"},{"issue":"4","key":"2026091519582315500_dgag172-B41","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1210\/clinem\/dgaa935","article-title":"Distant metastases from childhood differentiated thyroid carcinoma: clinical course and mutational landscape","volume":"106","author":"Nies","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026091519582315500_dgag172-B42","doi-asserted-by":"publisher","author":"Bendlova","DOI":"10.1530\/endoabs.101.PS2-11-08"},{"key":"2026091519582315500_dgag172-B43","article-title":"Locally invasive classical papillary thyroid carcinoma with TSH receptor I568T mutation: case report","volume":"2022","author":"Nguyen","year":"2022","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"5","key":"2026091519582315500_dgag172-B44","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/dc.23915","article-title":"Cancer risk and clinicopathological characteristics of thyroid nodules harboring thyroid-stimulating hormone receptor gene mutations","volume":"46","author":"Mon","year":"2018","journal-title":"Diagn Cytopathol"},{"issue":"6","key":"2026091519582315500_dgag172-B45","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-23-0049","article-title":"Activation of mitogen-activated protein kinase signaling and development of papillary thyroid carcinoma in thyroid-stimulating hormone receptor D633H knockin mice","volume":"12","author":"Eszlinger","year":"2023","journal-title":"Eur Thyroid J"},{"issue":"8","key":"2026091519582315500_dgag172-B46","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1210\/clinem\/dgaf090","article-title":"Approach to the pediatric patient with thyroid nodules","volume":"110","author":"Lai","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026091519582315500_dgag172-B47","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1089\/thy.2024.0109","article-title":"Changing clinical presentation of pediatric differentiated thyroid cancer in Poland: a retrospective cohort study spanning 45 years","volume":"34","author":"Kropinska","year":"2024","journal-title":"Thyroid"},{"issue":"4","key":"2026091519582315500_dgag172-B48","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-25-0035","article-title":"Risk-adapted therapy in pediatric thyroid cancer: initial experience from a national reference program by the MET group","volume":"14","author":"Kuhlen","year":"2025","journal-title":"Eur Thyroid J"},{"issue":"3","key":"2026091519582315500_dgag172-B49","doi-asserted-by":"crossref","DOI":"10.1530\/EC-22-0306","article-title":"Development of a pediatric differentiated thyroid carcinoma registry within the EuRRECa project: rationale and protocol","volume":"12","author":"Clement","year":"2023","journal-title":"Endocr Connect"},{"issue":"9","key":"2026091519582315500_dgag172-B50","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1177\/10507256251363978","article-title":"Clinical and pathological factors associated with disease persistence in pediatric patients with differentiated thyroid carcinoma","volume":"35","author":"De Leo","year":"2025","journal-title":"Thyroid"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag172\/68144544\/dgag172.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/10\/2837\/68144544\/dgag172.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/10\/2837\/68144544\/dgag172.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:58:35Z","timestamp":1789516715000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/10\/2837\/8661544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,4,22]]},"published-print":{"date-parts":[[2026,9,16]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgag172","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,4,22]]}}}